By Regulatory Approvals — AstraZeneca says FDA approves drug for rare kidney disease in adults Reuters
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 22, 2026.